Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma

Zhixian Wang1 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China, [email protected]

Xiaoyong Zeng1 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China, [email protected];2 Hubei Institute of Urology, Wuhan, China, [email protected]Correspondence[email protected]

Ruibao Chen1 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China, [email protected]

Zhiqiang Chen1 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China, [email protected];2 Hubei Institute of Urology, Wuhan, China, [email protected]

Pages 5339-5347 | Published online: 05 Nov 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ZhangBYThompsonRHLohseCMA novel prognostic model for patients with sarcomatoid renal cell carcinomaBJU Int2015115340541124730416
PubMed Web of Science ®Google Scholar
NguyenDPVilasecaAVertosickEAHistologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgicallyWorld J Urol201634453954426215750
PubMed Web of Science ®Google Scholar
ThomasAZAdibiMSlackRSThe role of metastasectomy in patients with renal cell carcinoma with sarcomatoid dedifferentiation: a matched controlled analysisJ Urol2016196367868427036304
PubMed Web of Science ®Google Scholar
ShuchBSaidJLarochelleJCHistologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapyCancer2010116361662419998348
PubMed Web of Science ®Google Scholar
ShuchBBratslavskyGShihJImpact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinomaBJU Int2012109111600160622221668
PubMed Web of Science ®Google Scholar
KimTZargar-ShoshtariKDhillonJUsing percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinomaClin Genitourin Cancer201513322523025544725
PubMed Web of Science ®Google Scholar
AdibiMThomasAZBorregalesLDPercentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiationUrol Oncol20153310427.e17427.e23
PubMed Web of Science ®Google Scholar
MolinaAMTickooSKIshillNSarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced diseaseAm J Clin Oncol201134545445921127411
PubMed Web of Science ®Google Scholar
WangZKimTBPengBSarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscapeClin Cancer Res201723216686669628710314
PubMed Web of Science ®Google Scholar
MaloufGGAliSMWangKGenomic characterization of renal cell carcinoma with sarcomatoid dedifferentiation pinpoints recurrent genomic alterationsEur Urol201670234835726895810
PubMed Web of Science ®Google Scholar
KeskinSKMsaouelPHessKROutcomes of patients with renal cell carcinoma and sarcomatoid dedifferentiation treated with nephrectomy and systemic therapies: comparison between the cytokine and targeted therapy erasJ Urol2017198353053728411072
PubMedGoogle Scholar
ConantJLPengZEvansMFNaudSCooperKSarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transitionJ Clin Pathol201164121088109222003062
PubMed Web of Science ®Google Scholar
VossMHBastosDAKarloCATreatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologiesAnn Oncol201425366366824458473
PubMed Web of Science ®Google Scholar
van PoppelHBeckerFCadedduJATreatment of localised renal cell carcinomaEur Urol201160466267221726933
PubMed Web of Science ®Google Scholar
ChoueiriTKMotzerRJSystemic therapy for metastatic renal-cell carcinomaN Engl J Med2017376435436628121507
PubMed Web of Science ®Google Scholar
MotzerRJHutsonTECellaDPazopanib versus sunitinib in metastatic renal-cell carcinomaN Engl J Med2013369872273123964934
PubMed Web of Science ®Google Scholar
GolshayanARGeorgeSHengDYMetastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapyJ Clin Oncol200927223524119064974
PubMed Web of Science ®Google Scholar
KuneneVMiscoriaMPirrieSIslamMRAfsharMPorfiriESarcomatoid renal cell carcinoma: clinical outcome and survival after treatment with sunitinibClin Genitourin Cancer201412425125524560086
PubMed Web of Science ®Google Scholar
KorenbaumCPierardLThiéryATreatments, outcomes, and validity of prognostic scores in patients with sarcomatoid renal cell carcinoma: a 20-year single-institution experienceClin Genitourin Cancer2018163e577e58629395949
PubMed Web of Science ®Google Scholar
PanerGPStadlerWMHanselDEMontironiRLinDWAminMBUpdates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancersEur Urol201873456056929325693
PubMed Web of Science ®Google Scholar
LjungbergBAlamdariFIStenlingRRoosGPrognostic significance of the Heidelberg classification of renal cell carcinomaEur Urol199936656556910559609
PubMed Web of Science ®Google Scholar
StörkelSEbleJNAdlakhaKClassification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)Cancer19978059879899307203
PubMed Web of Science ®Google Scholar
WangZXieHGuoLPrognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individualsCancer Manag Res2017967968929200888
PubMed Web of Science ®Google Scholar
HaasNBLinXManolaJA phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802Med Oncol201229276176721298497
PubMed Web of Science ®Google Scholar
Lopez-BeltranAScarpelliMMontironiRKirkaliZ2004 WHO classification of the renal tumors of the adultsEur Urol200649579880516442207
PubMed Web of Science ®Google Scholar
ChevilleJCLohseCMZinckeHSarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcomeAm J Surg Pathol200428443544115087662
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date